Citigroup Maintains Neutral on Insulet, Lowers Price Target to $165

Insulet Corporation

Insulet Corporation

PODD

0.00

Citigroup analyst Joanne Wuensch maintains Insulet (NASDAQ: PODD) with a Neutral and lowers the price target from $175 to $165.